news

BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent

Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent | Announcing the creation of AISF ([4-(Acetylamino)phenyl]- ...
March 19, 2018

BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities

BioDuro acquires Molecular Response to enhance translational oncology capabilities, providing access to a biobank of 100,000+ tumor specimens for drug discovery
March 05, 2018

BioDuro Announces Cooperation Agreement with Porton Pharma Solutions

BioDuro teams up with Porton Pharma Solutions to streamline global API and drug product development, aiming for accelerated timelines and efficient supply chains.
January 30, 2018

Sundia congratulates NHRI for DBPR114 IND approval in US & Taiwan

Sundia celebrates NHRI’s success with DBPR114, a multi-target kinase inhibitor approved for US and Taiwan INDs, supported by Sundia’s efficient CMC expertise.
November 07, 2017

Sundia’s VP, Dr. Russell Dahl was invited to attend SAPA-GP 15th Annual Conference

Sundia’s VP, Dr. Russell Dahl, attended the SAPA-GP 15th Annual Conference in Philadelphia, PA, from June 23-24, 2017, joining leaders from pharma, biotech ...
June 23, 2017

Sundia Receives 2016 Outstanding Contribution Enterprise Award by Shanghai Pudong Modern Service Industry Association

BioDuro-Sundia enhances drug discovery with advanced CADD services, leveraging cutting-edge computational tools for efficient, advanced preclinical research.
January 18, 2017

New Strategies Required to Meet Changing Needs in the Analytical Services Market

BioDuro introduces standalone analytical services to meet the growing demand for high-quality, rapid, cost-effective testing in the competitive pharmaceutical market
December 31, 2016

BioDuro Increases Spray Dried Drug Product Manufacturing Capacity

BioDuro expands spray drying capacity with the SPX Anhydro MicraSpray 150, enhancing solubility for drug candidates from preclinical to Phase 3 trials
November 08, 2016
Total 93 12...456789101112
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all